Sleep Consortium accelerates next-generation research and therapy development for Central Disorders of Hypersomnolence through a data collection ecosystem.
In our Patient Guidelines for Central Disorder of Hypersomnolence, we also have these helpful infographics that concisely detail all the ways CDoH can bring about other health issues.
https://t.co/ytTe0K02SC
#CDoH#centraldisordersofhypersomnolence#sleepconsortium
Unsure about joining the DREAMS Portal? We'll be doing a series highlighting the most frequently asked questions.
First, what is the Data Collection Program (DCP)?
Join the DREAMS portal by registering at https://t.co/mGuyJgO1GJ.
#DREAMSportal#BeCounted#sleepconsortium
Thank you for joining and supporting our #IlluminateIH Adjunct Scientific Meeting! In case you missed it, view the recording at https://t.co/zXAueYF4Go & share your thoughts by February
28. A summary report is coming this spring—stay tuned! #thisisIH
There's still time to register for the Illuminate Hypersomnia Adjunct Scientific Meeting happening February 13, 2025, from 12:00 – 2:00 p.m. EST.
Learn more and register here: https://t.co/fyIBWOSlpZ.
#IHPFDD#IlluminateIH#idiopathichypersomnia#sleepconsortium#thisisIH
What is brain fog? We define brain fog and more in our Patient Guidelines for Central Disorder of Hypersomnolence.
If you want to learn more, click the link in our bio to download the guidelines.
Click here to access the guidelines - https://t.co/ytTe0K02SC
#CDoH
Join us for the Illuminate Hypersomnia Adjunct Scientific Meeting on February 13, 2025, from 12 – 2 p.m. EST.
Dr. Lynne Marie Trotti will 'Recap of Illuminate Hypersomnia EL-PFDD.'
Learn more and register today: https://t.co/fyIBWOSlpZ
#IHPFDD#IlluminateIH#sleepconsortium
Disrupted sleep can impact every aspect of a person's life. In our Impact on Quality of Life chapter, we detail the ways CDoH may impact daily life.
Click here to access the guidelines - https://t.co/ytTe0K02SC
#CDoH#centraldisordersofhypersomnolence#sleepconsortium
Illuminate Hypersomnia Adjunct Scientific Meeting speaker announcement! We're thrilled to include the following panelists discussing - Considerations for Recruiting and Retaining People with IH in Research
Studies.
Register today: https://t.co/fyIBWOSlpZ
#IHPFDD#IlluminateIH
Our Patient Guidelines for Central Disorder of Hypersomnolence also have helpful infographics that guide us in creating a room that fosters better sleep hygiene.
https://t.co/ytTe0K02SC
#CDoH#centraldisordersofhypersomnolence#sleepconsortium
Join us for the Illuminate Hypersomnia Adjunct Scientific Meeting on February 13, 2025, from 12:00 – 2:00 p.m. EST Dr. Mignot will share insights into Barriers to Participation in Research Studies.
Register here - https://t.co/fyIBWOSlpZ
#IHPFDD#IlluminateIH
Do you feel that you may have a #sleepdisorder? In the Sleep Consortium's Patient Guidelines for Central Disorder of Hypersomnolence, we detail all the different types of tests available to receive a diagnosis.
https://t.co/ytTe0K02SC
#CDoH#centraldisordersofhypersomnolence
Illuminate Hypersomnia Adjunct Scientific Meeting speaker announcement! We're thrilled to include the following panelists discuss - Approaches to Better Defining and Measuring Brain Fog in IH.
Learn more and register today: https://t.co/fyIBWOSTfx
#IHPFDD#IlluminateIH#IH
In 2024, the Sleep Consortium released Patient Guidelines for Central Disorder of Hypersomnolence. In the specific symptomology, etiology, and clinical presentation chapter, we define central disorders of hypersomnolence (CDoH).
https://t.co/ytTe0K02SC
#idiopathichypersomnia
📢 Join the discussion on "Tackling the Drug Development Challenges for IH" on February 13th from 12–2 PM ET, hosted by @ConsortiumSleep.
Registration is free and encouraged. Learn more: https://t.co/D5enaMt2J8
Join us for the Illuminate Hypersomnia Adjunct Scientific Meeting on February 13, 2025, from 12:00 – 2:00 p.m. EST.
Dr. Michael Thorpy will share insights into Brain Fog.
Learn more and register today: https://t.co/fyIBWOSlpZ
#IHPFDD#IlluminateIH#idiopathichypersomnia
On April 11, 2024, the Illuminate Hypersomnia initiative will host an externally led virtual patient-focused drug development (PFDD) meeting, conducted as a parallel effort to the U.S. Food and Drug Administration’s PFDD initiative. Learn more: https://t.co/MbQEBqIK8p
Excited to present the new patient data connection and federation platform to advance research at the #hypersomniafoundation conference.
#sleepresearch